SGTX — Sigilon Therapeutics Share News
0.000.00%
Last trade - 00:00- $56.50m
- $17.21m
- $12.94m
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments (updated)
Sigilon jumps on Eli Lilly's buyout deal for more than $300 mln
Refinitiv Newscasts - U.S. Morning Call: Fed's Powell: Most US policymakers see two or more rate hikes ahead
Eli Lilly to acquire Sigilon Therapeutics in a deal worth over $300 million
Brief: Sigilon Announces Reverse Stock Split Of Common Stock
Sigilon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sigilon Therapeutics Reports Q1 2023 Financial Results And Business Highlights
Sigilon Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Sigilon Therapeutics Reports Q4 And Full Year 2022 Financial Results And Business Highlights
Sigilon Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Sigilon Therapeutics Inc - Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Sigilon Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
Sigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary